Genomic Press May 13 2025 In a comprehensive Genomic Press Commentary published today, researchers have identified what could be the first reliable biomarker for depression risk, potentially transforming how this devastating condition is identified and treated. The commentary examines recent findings demonstrating that individuals with depression consistently exhibit a functionally enlarged salience network compared to non-depressed controls. Distinctive brain connectivity pattern identified